Zobrazeno 1 - 10
of 14
pro vyhledávání: '"F. Vaillant"'
Autor:
Lauranne Schoneveld, Julien Guiot, Etienne Cavalier, Michel Moutschen, Anne Noelle Frix, Benoit Misset, Bernard Duysinx, Renaud Louis, F Vaillant, Monique Henket, Aurélie Ladang
Publikováno v:
Respiratory Research
Background Coronavirus disease COVID-19 has become a public health emergency of international concern. Together with the quest for an effective treatment, the question of the post-infectious evolution of affected patients in healing process remains u
Publikováno v:
Revue des Maladies Respiratoires. 36:688-696
Resume Introduction L’incidence des maladies de la plevre continue a augmenter a travers le monde. La thoracoscopie medicale demeure l’examen de reference dans l’exploration de la cavite pleurale. Methode Nous rapportons l’evaluation retrospe
Autor:
Guillaume Fond, Philippe Le Corvoisier, F Schürhoff, A Szöke, Face-Sz Groups, I Offerlin-Meyer, Ryad Tamouza, T D′Amato, I Chéreau, J Dubreucq, E Vilà, F Gabayet, Julien Dubreucq, C Fluttaz, Wahid Boukouaci, D Misdrahi, P Vidailhet, David Misdrahi, J Mallet, B Pignon, Caroline Barau, A Vehier, C Lançon, Myrtille André, Jasmina Mallet, Baptiste Pignon, H Yazbek, Julie Clauss-Kobayashi, Christine Passerieux, J M Dorey, Caroline Dubertret, Sylvain Leignier, K Souryis, P Peri, Isabelle Chereau, F Berna, O Blanc, G Chesnoy-Servanin, S Pires, D Lacelle, A Deloge, Franck Schürhoff, Hakim Laouamri, P M Llorca, O Godin, Bruno Aouizerate, C. Portalier, Pierre-Michel Llorca, R Rey, A Zinetti-Bertschy, H Denizot, Mathieu Urbach, M Jarroir, V Barteau, C Roman, B Aouizerate, C Passerieux, S Esselin, R M Honciuc, C Dubertret, Christophe Lançon, H. Laouamri, F Vaillant, Andrei Szöke, E Metairie, Marion Leboyer, Ching-lieng Lu, M Urbach, Fabrice Berna, C Faget, Romain Rey, Ophélia Godin, E Haffen, M Leboyer, D Capdevielle, Delphine Capdevielle, Thierry D′Amato, S Bensalem, Emilie Terro
Publikováno v:
Schizophrenia Bulletin Open
Treatment-resistant schizophrenia (TRS) affects around 30% of patients with schizophrenia (SZ) resulting in poor functioning, relapses, and reduced quality of life. Convergent findings show that inflammation could contribute to resistance. We thus se
Autor:
Florence Schleich, Olivier Bonhomme, Mathieu Debruche, Alexandre Ghuysen, Michel Moutschen, A Paulus, Hélène Van Cauwenberge, Fanny Gester, Benoit Misset, Marie Thys, Bernard Duysinx, Julien Berg, Jean-Louis Corhay, Delphine Nguyen Dang, Vincent Heinen, Doriane Calmes, Anne-Noëlle Frix, A Sibille, Pierre Gillet, Monique Henket, F Vaillant, Nathalie Maes, Julien Guiot, Michel Malaise, Valérie Quaedvlieg, Sophie Graff, Alisson Gilbert, Renaud Louis, Virginie Paulus
Publikováno v:
The Journal of Allergy and Clinical Immunology: In Practice
The Journal of Allergy and Clinical Immunology. in Practice
The Journal of Allergy and Clinical Immunology. in Practice
Background Asthmatics and COPD patients have more severe outcomes with viral infections than people without obstructive disease. Objective To evaluate if obstructive diseases are risk factors for ICU stay and death due to COVID19. Methods We collecte
Autor:
J. Guiot, M. Henket, A.N. Frix, M. Delvaux, A. Denis, L. Giltay, M. Thys, F. Gester, M. Moutschen, J.L. Corhay, R. Louis, A. Ancion, A. Bouquegneau, C. Bovy, G. Darcis, J.O. Defraigne, B. Duysinx, A. Ghuysen, A. Gilbert, V. Heinen, B. Lambermont, O. Malaise, M. Martin, B. Misset, D. Nguyen Dang, J. Piazza, J. Szecel, F. Vaillant, H. Van Cauwenberge, C. Von Frenckell, L. Vroonen
Publikováno v:
Respiratory Investigation
Introduction Patients with interstitial lung diseases (ILD) can be suspected to be at risk of experiencing a rapid flare-up due to COVID-19. However, no specific data are currently available for these patients. Methods We retrospectively analyzed a c
Autor:
Nathalie Marchal, Marie Goffin, Marie Lecocq, Amandine Catot, Concetta Elisa Onesti, Elodie Gonne, Odile Wera, Laurence Nicolaers, Aurélie Poncin, Joëlle Collignon, Andrée Rorive, Christine Gennigens, Bernard Duysinx, Guy Jerusalem, Hélène Schroeder, Pierre Frères, F Vaillant, Marc Polus, Brieuc Sautois, Astrid Collinge
Publikováno v:
Annals of Oncology
Background: No specific safety data concerning systemic oncological treatments were available at time of COVID-19 outbreak in Belgium. In our hospital we decided to maintain adjuvant and early line treatments for metastatic disease in patients under
Autor:
GJ Lindeman, E Nolan, F Vaillant, D Branstetter, B Pal, G Giner, L Whitehead, SW Lok, GB Mann, Consortium kConFab, K Rohrbach, L-Y Huang, R Soriano, GK Smyth, WC Dougall, JE Visvader
Publikováno v:
Cancer Research. 77:S2-04
Background: BRCA1 mutation carriers commonly undergo prophylactic mastectomy to reduce their risk of breast cancer. The precise role of chemoprevention with tamoxifen, which reduces the incidence of ER-positive breast cancer in the general population
Autor:
G. Fond, L. Boyer, M. Andrianarisoa, O. Godin, L. Brunel, E. Bulzacka, N. Coulon, P.M. Llorca, F. Berna, B. Aouizerate, D. Capdevielle, T. D'Amato, C. Dubertret, J. Dubreucq, C. Faget, F. Gabayet, J. Mallet, D. Misdrahi, R. Rey, R. Richieri, P. Roux, C. Passerieux, A. Schandrin, A.M. Tronche, P. Vidailhet, M. Leboyer, F. Schürhoff, O. Blanc, I. Chereau-Boudet, G. Chesnoy-Servanin, J.M. Danion, A. Deloge, C. Delorme, H. Denizot, J.M. Dorey, C. Fluttaz, S. Fonteneau, E. Giraud-Baro, M.C. Hardy-Bayle, D. Lacelle, C. Lançon, H. Laouamri, T. Le Gloahec, Y. Le Strat, E. Metairie, I. Offerlin-Meyer, P. Peri, S. Pires, C. Portalier, C. Roman, M. Sebilleau, F. Schurhoff, A. Tessier, M. Urbach, F. Vaillant, A. Vehier, E. Vilà, H. Yazbek, A. Zinetti-Bertschy
Publikováno v:
Schizophrenia Research
Schizophrenia Research, Elsevier, 2018, ⟨10.1016/j.schres.2017.08.058⟩
Schizophrenia Research, 2018, ⟨10.1016/j.schres.2017.08.058⟩
Schizophrenia Research, Elsevier, 2018, ⟨10.1016/j.schres.2017.08.058⟩
Schizophrenia Research, 2018, ⟨10.1016/j.schres.2017.08.058⟩
Objectives Reducing the duration of untreated psychosis (DUP) may improve the prognosis of schizophrenia. This study investigated the prevalence, and associated risk factors, of long DUP in a large, non-selected sample of community-dwelling schizophr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cd7c609f1c2ca09f3e7c9d4087253ec
https://hal.uca.fr/hal-01696808
https://hal.uca.fr/hal-01696808
Autor:
Paul Roux, Mathieu Urbach, Sandrine Fonteneau, Fabrice Berna, Lore Brunel, Delphine Capdevielle, Isabelle Chereau, Julien Dubreucq, Catherine Faget-Agius, Guillaume Fond, Sylvain Leignier, Claire-Cécile Perier, Raphaëlle Richieri, Priscille Schneider, Franck Schürhoff, Anne-Marie Tronche, Hanan Yazbek, Anna Zinetti-Bertschy, Christine Passerieux, Eric Brunet-Gouet, M. Andrianarisoa, B. Aouizerate, N. Bazin, F. Berna, O. Blanc, L. Brunel, E. Bulzacka, D. Capdevielle, I. Chereau-Boudet, G. Chesnoy-Servanin, Jm Danion, T. D'Amato, A. Deloge, C. Delorme, H. Denizot, J.M. Dorey, C. Dubertret, J. Dubreucq, C. Faget, C. Fluttaz, G. Fond, S. Fonteneau, F. Gabayet, E. Giraud-Baro, D. Lacelle, C. Lançon, H. Laouamri, M. Leboyer, T. Le Gloahec, Y. Le Strat, null Llorca, J. Mallet, E. Metairie, D. Misdrahi, I. Offerlin-Meyer, C. Passerieux, P. Peri, S. Pires, C. Portalier, L. Ramet, R. Rey, C. Roman, A. Schandrin, F. Schürhoff, A. Tessier, Am Tronche, M. Urbach, F. Vaillant, A. Vehier, P. Vidailhet, E. Vilà, H. Yazbek, A. Zinetti-Bertschy
Publikováno v:
Schizophrenia Research
Schizophrenia Research, 2018, 201, pp.196-203. ⟨10.1016/j.schres.2018.06.021⟩
Schizophrenia Research, Elsevier, 2018, 201, pp.196-203. ⟨10.1016/j.schres.2018.06.021⟩
Schizophrenia Research, 2018, 201, pp.196-203. ⟨10.1016/j.schres.2018.06.021⟩
Schizophrenia Research, Elsevier, 2018, 201, pp.196-203. ⟨10.1016/j.schres.2018.06.021⟩
International audience; The functional outcome in schizophrenia spectrum disorders is affected by multiple factors such as cognitive performance and clinical symptoms. Psychiatric disability may be another important determinant of functional outcome.
Autor:
J. Mallet, Y. Le Strat, F. Schürhoff, N. Mazer, C. Portalier, M. Andrianarisoa, B. Aouizerate, F. Berna, L. Brunel, D. Capdevielle, I. Chereau, T. D'Amato, H. Denizot, J. Dubreucq, C. Faget, F. Gabayet, C. Lançon, P.M. Llorca, D. Misdrahi, R. Rey, P. Roux, A. Schandrin, M. Urbach, P. Vidailhet, G. Fond, C. Dubertret, N. Bazin, O. Blanc, E. Bulzacka, I. Chereau-Boudet, G. Chesnoy-Servanin, J.M. Danion, A. Deloge, C. Delorme, J.M. Dorey, C. Fluttaz, S. Fonteneau, E. Giraud-Baro, D. Lacelle, H. Laouamri, M. Leboyer, T. Le Gloahec, E. Metairie, I. Offerlin-Meyer, C. Passerieux, P. Peri, S. Pires, L. Ramet, C. Roman, A. Tessier, A.M. Tronche, F. Vaillant, A. Vehier, E. Vilà, H. Yazbek, A. Zinetti-Bertschy
Publikováno v:
Progress in Neuro-Psychopharmacology and Biological Psychiatry
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Elsevier, 2017, 79, pp.332-339. ⟨10.1016/j.pnpbp.2017.06.026⟩
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2017, 79, pp.332-339. ⟨10.1016/j.pnpbp.2017.06.026⟩
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Elsevier, 2017, 79, pp.332-339. ⟨10.1016/j.pnpbp.2017.06.026⟩
Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2017, 79, pp.332-339. ⟨10.1016/j.pnpbp.2017.06.026⟩
Background Tobacco use is common in patients with schizophrenia (SZ) but little is known on the role of tobacco in the physiopathology or on the course of the disease. Only few studies embrace an extensive examination of clinical and therapeutic char
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bcf9c4589e9d62b86512a414504763ad
https://hal.uca.fr/hal-01696847
https://hal.uca.fr/hal-01696847